Teva’s Generic EpiPen Will Cost As Much As Mylan’s Generic

Teva Pharmaceutical Industries announced Tuesday that its much-anticipated generic EpiPen is now available “in limited quantity” in the U.S. — at the same $300 list price as manufacturer Mylan’s authorized generic version.

Teva was in August granted Food and Drug Administration (FDA) approval for the first generic version of the EpiPen and lower-dose EpiPen Jr. The approval was heralded as a win for patient choice, as the generic would offer allergy sufferers an alternative to Mylan’s version of the anaphylaxis-reversing auto-injector, which had over time risen in price to cost $608 for a two-pack. FDA Commissioner Dr. Scott Gottlieb said in a statement at the time that, “This approval means patients living with severe allergies who require constant access to life-saving epinephrine should have a lower-cost option, as well as another approved product to help protect against potential drug shortages.”

While the availability of Teva’s product may help cut into some of the EpiPen shortage issues that have plagued Mylan in recent months, it appears to have fallen somewhat short of Gottlieb’s hopes around affordability. Teva’s $300 wholesale acquisition cost is lower than the $608 Mylan charges for its name-brand product, but Mylan also offers an authorized generic two-pack that, just like Teva’s version, costs $300. The majority of Mylan’s auto-injector prescriptions are filled with its authorized generic, a company representative told TIME.

An authorized generic is an exact replica of a brand-name drug that is simply sold without that branding on its packaging, according to the FDA. A true generic, meanwhile, is a copy of a brand-name drug that is made by another company and may have minor differences in its inactive ingredients.

Representatives from Teva could not immediately be reached for further comment. But in a company release, Brendan O’Grady, Teva’s executive vice president and head of North America Commercial, said the company is “pleased to provide access to Epinephrine Injection (Auto-Injector) for patients who may experience life-threatening allergic emergencies and we’re fully dedicated toward ensuring additional supply in 2019.”

Epinephrine auto-injectors, such as Mylan and Teva’s, combat life-threatening allergic reactions to things like peanuts and bee stings through an injection in the thigh. Epinephrine can reverse these reactions by reducing airway swelling to improve breathing and increasing heart rate and blood pressure.

Write to Jamie Ducharme at jamie.ducharme@time.com.


Source link

About MustafaMehar

Hi,im Ghulam Mustafa Mehar "Chief Executive World Institute for Genius Mind" Trainor Online telepathy Master Course ,Editor, writer&Web developer

Check Also

Decoding Childhood Allergies and Letting Kids Get Dirty With Dr. Amy Shah

Dr. Amy Shah on Childhood Allergies & Why Kids Need Dirt

233: Decoding Childhood Allergies and Letting Kids Get Dirty With Dr. Amy Shah &nbsp Today …

PhenQ Side Effects | Know Whether It’s Safe for you or Not!!

One of the most important aspects to take into consideration when looking for a weight …

On Starting a Business & Creating An Inspiring Life (PART 5): TAKE THE QUIZ: 22 Ways To Tell If Starting A Creative Business Right For You

NOTE: B-School is now closed for the year. This is probably the longest post I …

Doing Physical and Mental Exercise When You’re Younger May Help Ward Off Dementia

Doing Physical and Mental Exercise When You’re Younger May Help Ward Off Dementia | Time …

Prescription Drugs Are Ground Zero for AI Innovation In Patient-Centric Healthcare

Feb20 Prescription Drugs Are Ground Zero for AI Innovation In Patient-Centric Healthcare By Leslie Swanson, …

Is it Bad to Sleep with Wet Hair?

Is it Bad to Sleep with Wet Hair? | Time this link is to an …

Print Friendly, PDF & Email

How to Create a DIY Plant Wall In Your Home

I’ve already confessed my weird hobby of taking on remodeling projects whenever my husband leaves …

Leave a Reply

Your email address will not be published. Required fields are marked *